Treatment patterns and outcomes in patients with non‐small cell lung cancer receiving biosimilar filgrastim for prophylaxis of chemotherapy‐induced/febrile neutropaenia: Results from the MONITOR‐GCSF study
Aapro, Matti ; Krendyukov, Andriy ; Höbel, Nadja ; Gascon, Pere
European journal of cancer care, 2019-07, Vol.28 (4), p.e13034-n/a [Periódico revisado por pares]England: Hindawi Limited
Texto completo disponível